Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-042697
Filing Date
2025-05-13
Accepted
2025-05-13 16:37:27
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0240397-10q_therape.htm   iXBRL 10-Q 520444
2 CERTIFICATION ea024039701ex31-1_therape.htm EX-31.1 9885
3 CERTIFICATION ea024039701ex31-2_therape.htm EX-31.2 9847
4 CERTIFICATION ea024039701ex32-1_therape.htm EX-32.1 4320
5 CERTIFICATION ea024039701ex32-2_therape.htm EX-32.2 4326
  Complete submission text file 0001213900-25-042697.txt   4384384

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20250331.xsd EX-101.SCH 49399
7 XBRL CALCULATION FILE txmd-20250331_cal.xml EX-101.CAL 34056
8 XBRL DEFINITION FILE txmd-20250331_def.xml EX-101.DEF 199645
9 XBRL LABEL FILE txmd-20250331_lab.xml EX-101.LAB 392189
10 XBRL PRESENTATION FILE txmd-20250331_pre.xml EX-101.PRE 218476
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0240397-10q_therape_htm.xml XML 429355
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 25940813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)